Comparing Smith & Nephew and FitLife Brands in the Medical Industry

An analysis of the two companies' financials, performance, and analyst recommendations

Jan. 31, 2026 at 5:47am

Got story updates? Submit your updates here. ›

Smith & Nephew SNATS (NYSE:SNN) and FitLife Brands (NASDAQ:FTLF) are both medical companies, but which one is the better business? This article compares the two companies based on factors like risk, profitability, earnings, dividends, institutional ownership, analyst recommendations, and valuation.

Why it matters

Investors looking to invest in the medical industry may be interested in understanding the differences between these two companies and which one may be the better investment option based on their financial performance and market positioning.

The details

The analysis finds that FitLife Brands has a stronger consensus rating from analysts and a higher potential upside compared to Smith & Nephew. FitLife Brands also outperforms Smith & Nephew on 7 out of 13 factors compared, including net margins, return on equity, and return on assets. However, Smith & Nephew has a lower beta, indicating lower volatility compared to the overall market.

  • The article was published on January 31, 2026.

The players

Smith & Nephew SNATS

A medical device company that develops, manufactures, and sells products for orthopaedics, sports medicine, and advanced wound management.

FitLife Brands

A provider of nutritional supplements for health-conscious consumers in the United States and internationally.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights the differences between these two medical companies and suggests that FitLife Brands may be the more favorable investment option based on its stronger financial performance and higher potential upside according to analyst recommendations.